These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 2388474)

  • 41. Use of granulocyte-macrophage colony-stimulating factor (GM-CSF) in combination with hydroxyurea as post-transplant therapy in chronic myelogenous leukemia patients autografted with unmanipulated hematopoietic cells.
    Carlo-Stella C; Regazzi E; Andrizzi C; Savoldo B; Garau D; Montefusco E; Vignetti M; Mandelli F; Rizzoli V; Meloni G
    Haematologica; 1997; 82(3):291-6. PubMed ID: 9234574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Changes in granulocyte-monocyte colony-forming cells among leukocyte-interferon-treated chronic myelogenous leukemia patients.
    Talpaz M; Spitzer G; Hittelman W; Kantarjian H; Gutterman J
    Exp Hematol; 1986 Aug; 14(7):668-71. PubMed ID: 3460811
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia.
    Freedman MH; Cohen A; Grunberger T; Bunin N; Luddy RE; Saunders EF; Shahidi N; Lau A; Estrov Z
    Br J Haematol; 1992 Jan; 80(1):40-8. PubMed ID: 1311195
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies raised against K562 cells reacted with human haematopoietic pluripotent stem cells.
    Kubota Y; Tanaka T; Irino S
    Leuk Res; 1991; 15(4):195-204. PubMed ID: 2030600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors influencing the haematological recovery after allogeneic bone marrow transplantation in leukaemia patients treated with methotrexate-containing GVHD prophylaxis: a single-centre experience.
    Hassan HT; Krog C; Stockschläder M; Schleimer B; Zeller W; Krüger W; Erttmann R; Zander AR
    Anticancer Res; 1997; 17(1B):589-99. PubMed ID: 9066585
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells.
    Broxmeyer HE; Lu L; Platzer E; Feit C; Juliano L; Rubin BY
    J Immunol; 1983 Sep; 131(3):1300-5. PubMed ID: 6193183
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of human alpha-interferon on granulocyte-macrophage progenitor cells (CFU-GM) in vitro.
    Schwamborn JS; Nickels RM; Katthagen BD; Pees HW; Scheurlen PG
    Blut; 1988 Mar; 56(3):107-9. PubMed ID: 3355900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of cyclosporin A used alone and in combination with either 2-chlorodeoxyadenosine or fludarabine on normal and chronic myelogenous leukemia progenitors in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 2003; 51(1):61-7. PubMed ID: 12691305
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in vitro effect of high-dose recombinant human erythropoietin on granulocyte-macrophage colony production in premature infants using a defined serum deprived cell culture system.
    Ward CS; Westwood NB; Emmerson AJ; Pearson TC
    Br J Haematol; 1992 Jul; 81(3):325-30. PubMed ID: 1382542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. In vitro effects of human recombinant alpha-2b interferon on Ph1+ chronic myelogenous leukemia cells maintained in long term marrow cultures: a functional and morphological analysis.
    Sandrelli A; De Fabritiis P; Cafolla A; Nanni M; Simone F; De Felice L; Di Nucci GD; Mandelli F
    J Biol Regul Homeost Agents; 1989; 3(3):102-7. PubMed ID: 2624145
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of retinoic acid and interferon alpha on granulocyte-macrophage colony forming cells in chronic myeloid leukemia: increased inhibition by all-trans- and 13-cis-retinoic acids in advanced stage disease.
    Sagayadan GE; Wiernik PH; Sun N; Ahearn G; Thompson D; Hallam SJ; Hu XP; Dutcher JP; Gallagher RE
    Leuk Res; 1994 Oct; 18(10):741-8. PubMed ID: 7934131
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The maintenance of busulphan-induced remissions in chronic granulocytic leukaemia with recombinant interferon alpha-2b.
    Bergsagel DE; Messner H
    Br J Cancer; 1990 Jun; 61(6):895-8. PubMed ID: 2372493
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursor cells.
    Murphy M; Perussia B; Trinchieri G
    Exp Hematol; 1988 Feb; 16(2):131-8. PubMed ID: 3123270
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Growth of human hematopoietic colonies from patients with myelodysplastic syndromes in response to recombinant human granulocyte-macrophage colony-stimulating factor.
    Carlo-Stella C; Cazzola M; Bergamaschi G; Bernasconi P; Dezza L; Invernizzi R; Pedrazzoli P
    Leukemia; 1989 May; 3(5):363-6. PubMed ID: 2654496
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sensitivity of committed hematopoietic progenitor cells in vitro (BFU-E, CFU-E, CFU-GM) and two human carcinoma cell lines toward rhodamine-123 and phosphonium salt II-41.
    Sehy DW; Shao LE; Rideout D; Yu J
    Leuk Res; 1993 Mar; 17(3):247-53. PubMed ID: 8450673
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant alpha-interferon inhibits colony formation of bone marrow fibroblast progenitor cells (CFU-F).
    Wang JC; Lang HD; Liao P; Wong A
    Am J Hematol; 1992 Jun; 40(2):81-5. PubMed ID: 1533991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction of transforming growth factor-beta 1 with hemopoietic growth factors in the regulation of human normal and leukemic myelopoiesis.
    Aglietta M; Stacchini A; Severino A; Sanavio F; Ferrando ML; Piacibello W
    Exp Hematol; 1989 Mar; 17(3):296-9. PubMed ID: 2783914
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interferon-alpha alters the distribution of CFU-GM between the adherent and nonadherent compartments in long-term cultures of chronic myeloid leukemia marrow.
    Osterholz J; Dowding C; Guo AP; Siczkowski M; Goldman JM
    Exp Hematol; 1991 Jun; 19(5):326-31. PubMed ID: 2026184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of interleukin-11 on the hematopoietic action of granulocyte colony-stimulating factor.
    Momose K; Taguchi K; Saitoh M; Yasuda S; Miyata K
    Arzneimittelforschung; 2002; 52(11):857-61. PubMed ID: 12489258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.